SEC Form 4 · accession 0001192482-18-000251
COLLEGIUM PHARMACEUTICAL, INC · COLL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Hirsch
Director
Period of report
May 24, 2018
Accepted (ET)
May 29, 2018 · 5:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267565
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 24, 2018 | A | 2,253 | $0.00 | A | 27,193 | D | |
| Common StockF3,F4 | holding | — | — | — | 15,208 | I | By: Longitude Capital Associates, L.P. | |
| Common StockF5,F4 | holding | — | — | — | 758,742 | I | By: Longitude Venture Partners, L.P. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Purchase)F6 | $24.95 | May 24, 2018 | A | 4,506 | A | — | May 24, 2028 | Common Stock | 4,506 | 4,506 | D |
Explanation of responses
- F1Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 24, 2019, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date in shares of the issuer's common stock.
- F2Includes 24,940 shares received in distributions from Longitude Venture Partners, L.P. ("LVP") and Longitude Capital Associates, L.P. ("LCA").
- F3Reflects 30,412 shares distributed by LCA to its limited partners. In prior reports, the reporting person reported indirect beneficial ownership of 45,620 shares of common stock of the issuer held by LCA.
- F4Longitude Capital Partners, LLC ("LCP") is the general partner of LVP and LCA. The reporting person is a member of LCP, has the power to vote and dispose of the securities of the issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. The reporting person disclaims beneficial ownership of the securities of the issuer held by LVP and LCA except to the extent of his pecuniary interest therein.
- F5Reflects 1,517,480 shares distributed by LVP to its limited partners. In prior reports, the reporting person reported indirect beneficial ownership of 2,276,222 shares of common stock of the issuer held by LVP.
- F6The option vests and becomes exercisable on May 24, 2019, subject to the director's continued service with the issuer.